Ovarian Cancer Market Research Reports

Your Ovarian Cancer Market Guide with research reports, industry analysis, market forecasts, market share, size, etc.
RSS Sort By :
TITLE Price Buy Now More options

In this report, the global Ovarian Cancer Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split global int...

$ 4000


In this report, the global Ovarian Cancer Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segme...

$ 2900


Increase in usage of biotechnological technologies in the development of anticancer drugs such as immunotherapies or monoclonal antibodies, adoptive-cell therapies, and new vaccines is an emerging trend in this market. Major competitors such as Roche...

$ 4000


DelveInsight’s “Epithelial Ovarian Cancer - Market Insights, Epidemiology and Market Forecast – 2025” Reports provides an overview of the disease and global market size of the Epithelial Ovarian Cancer for the 7MM (United States, Germany, France, ...

$ 5750


DelveInsight’s, “ Epithelial Ovarian Cancer -Pipeline Insights, 2017”, report provides comprehensive insights about pipeline drugs across this Epithelial Ovarian Cancer. The key objective of the report is to establish the understanding for all the pi...

$ 2000


DelveInsight “ Epithelial Ovarian Cancer - Epidemiology Forecast To 2025” provides an overview of the epidemiology trends of Epithelial Ovarian Cancer in seven major markets (US, France, Germany, Italy, Spain, UK and Japan). It includes 10 years epid...

$ 2950


DelveInsight’s, Epithelial Ovarian Cancer - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017” report provides comprehensive insights about marketed and Phase III products for the Epithelial Ovarian Cancer. The report includes in...

$ 2000


Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Ovarian Cancer - Pipeline Review, H1 2017, provides an overview of the Ovarian Cancer (Oncology) pipeline landscape.Ovarian cancer is any cancerous growth that may...

$ 2500


OpportunityAnalyzer: Ovarian Cancer - Opportunity Analysis and Forecasts to 2025 Summary Ovarian cancer is the fifth most common malignancy in women and is the leading cause of death among gynecological cancers. Due to the n...

$ 10995


This study focuses on China’s Ovarian Cancer Treatment Drugs industry assessments and company profiles. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consum...

$ 1800


China's demand for Ovarian Cancer Treatment Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the co...

$ 4000


This study focuses on China’s Ovarian Cancer Treatment Drugs industry forecasts. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in Chin...

$ 1800


This report studies Ovarian Cancer Drugs in Global market, especially in North America, Europe, China, Japan, Latin America and India, focuses on top manufacturers in global market, with capacity, production, price, revenue and market share for each ...

$ 2955


Notes: Production, means the output of Ovarian Cancer Drugs Revenue, means the sales value of Ovarian Cancer Drugs This report studies Ovarian Cancer Drugs in Global market, especially in North America, Europe, China, Jap...

$ 2900


Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Ovarian Cancer – Pipeline Review, H2 2016, provides an overview of the Ovarian Cancer (Oncology) pipeline landscape.Ovarian cancer is any cancerous growth that may...

$ 2500


Ovarian cancer (International Classification of Diseases, 10th Revision [ICD-10] code C56) and cancer of the fallopian tubes and other uterine adnexa (ICD-10 C57) are leading causes of cancer mortality in women (ACS, 2016; CDC, 2016). Cancer of th...

$ 3995


Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Epithelial Ovarian Cancer – Pipeline Review, H2 2016, provides an overview of the Epithelial Ovarian Cancer (Oncology) pipeline landscape.Ovarian epithelial cancer...

$ 2000


The global women’s health diagnostics market is projected to reach USD 36.64 billion by 2021, growing at a CAGR of around 7.9% during the forecast period. Growth in this market can be attributed to a number of factors such as high prevalence...

$ 5650


Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Metastatic Ovarian Cancer – Pipeline Review, H2 2016, provides an overview of the Metastatic Ovarian Cancer (Oncology) pipeline landscape.Metastatic ovarian cancer...

$ 2000


Ovarian Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2016 Summary GlobalData''s Medical Devices sector report, “Ovarian Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2016" provides an overvi...

$ 4000

Email Us
Need Help?
Name
Email
Phone
Country
Subject
Comments

Connect With Us
Email: sales@reportsandreports.com Call : + 1 888 391 5441
Subscription Option

Use our subscription option and keep yourself updated about the latest industry analysis reports. We have research reports for over 5000 micro markets; you can access and utilize them at economical budgets.

More about our Subscription option
Report Alerts

Get Email alerts about market research reports from industries and publishers of your interest: